2026 대한장연구학회 염증성 장질환 진단 및 모니터링 가이드라인
21 affiliations
- 1한림대학교 의과대학 춘천성심병원 내과학교실
- 2성균관대학교 의과대학 삼성서울병원 내과학교실
- 3중앙대학교 의과대학 내과학교실
- 4대구가톨릭대학교 의과대학 내과학교실
- 5전남대학교 의과대학 내과학교실
- 6부산대학교 의과대학 내과학교실
- 7부산대학교병원 소화기내과
- 8부산대학교병원 의생명연구원
- 9이화여자대학교 의과대학 내과학교실
- 10한림대학교 의과대학 강동성심병원 내과학교실
- 11가톨릭대학교 의과대학 대전성모병원 내과학교실
- 12경북대학교 의과대학 내과학교실
- 13조선대학교 의과대학 내과학교실
- 14가톨릭대학교 의과대학 인천성모병원 내과학교실
- 15연세대학교 의과대학 내과학교실 및 소화기병연구소
- 16울산대학교 의과대학 서울아산병원 소화기내과
- 17연세대학교 원주의과대학 원주의학도서관
- 18한국보건의료연구원
- 19울산대학교 의과대학 서울아산병원 병리과
- 20성균관대학교 의과대학 삼성서울병원 병리과
- 21연세대학교 의과대학 세브란스병원 영상의학과
Abstract
Inflammatory bowel disease (IBD) is characterized by heterogeneous disease presentations and clinical courses. Accurate diagnosis and appropriate disease monitoring play an important role in improving long-term outcomes by preventing misdiagnosis and unnecessary treatment; enabling early detection of disease progression, treatment failure, and disease-related complications; and facilitating timely adjustment of treatment strategies. The Korean Association for the Study of Intestinal Diseases (KASID) developed guidelines for the diagnosis and monitoring of IBD in adults, reflecting the Korean clinical setting, to support clinical decision-making and improve the quality of patient care. To develop these guidelines, existing international clinical practice guidelines and expert consensus statements were comprehensively reviewed, along with updated evidence relevant to each clinical topic. Final recommendations were established through expert consensus using a modified Delphi process. These guidelines address major clinical areas in the diagnosis and monitoring of IBD, including initial diagnosis and baseline assessment, assessment of disease extent and activity, disease monitoring in ulcerative colitis and Crohn’s disease, nutritional assessment, and colorectal cancer surveillance. These guidelines are intended to support individualized clinical judgment and should be applied flexibly, taking into account not only individual patient characteristics and clinical circumstances but also available resources, access to diagnostic and monitoring modalities, regulatory requirements, and reimbursement policies.
Related
BibTeX
@article{양20262026,
title = {{2026 대한장연구학회 염증성 장질환 진단 및 모니터링 가이드라인}},
author = {영주 양 and 지은 김 and 승용 신 and 준화 배 and 동현 김 and 승민 홍 and 은미 송 and 지영 윤 and 상범 강 and 은수 김 and 성은 김 and 성중 김 and 준 이 and 수영 나 and 수정 박 and 상형 박 and 명하 김 and 미영 최 and 지훈 김 and 상윤 하 and 니은 서 and 혜영 김 and 원 문 and 성애 정 and 대한장연구학회 가이드라인위원회},
journal = {The Korean Journal of Gastroenterology},
year = {2026},
month = oct,
doi = {10.4166/kjg.2026.093},
url = {https://doi.org/10.4166/kjg.2026.093},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - 2026 대한장연구학회 염증성 장질환 진단 및 모니터링 가이드라인
AU - 영주 양
AU - 지은 김
AU - 승용 신
AU - 준화 배
AU - 동현 김
AU - 승민 홍
AU - 은미 송
AU - 지영 윤
AU - 상범 강
AU - 은수 김
AU - 성은 김
AU - 성중 김
AU - 준 이
AU - 수영 나
AU - 수정 박
AU - 상형 박
AU - 명하 김
AU - 미영 최
AU - 지훈 김
AU - 상윤 하
AU - 니은 서
AU - 혜영 김
AU - 원 문
AU - 성애 정
AU - 대한장연구학회 가이드라인위원회
PY - 2026
DA - 2026/10/25
JO - The Korean Journal of Gastroenterology
DO - 10.4166/kjg.2026.093
UR - https://doi.org/10.4166/kjg.2026.093
AB - Inflammatory bowel disease (IBD) is characterized by heterogeneous disease presentations and clinical courses. Accurate diagnosis and appropriate disease monitoring play an important role in improving long-term outcomes by preventing misdiagnosis and unnecessary treatment; enabling early detection of disease progression, treatment failure, and disease-related complications; and facilitating timely adjustment of treatment strategies. The Korean Association for the Study of Intestinal Diseases (KASID) developed guidelines for the diagnosis and monitoring of IBD in adults, reflecting the Korean clinical setting, to support clinical decision-making and improve the quality of patient care. To develop these guidelines, existing international clinical practice guidelines and expert consensus statements were comprehensively reviewed, along with updated evidence relevant to each clinical topic. Final recommendations were established through expert consensus using a modified Delphi process. These guidelines address major clinical areas in the diagnosis and monitoring of IBD, including initial diagnosis and baseline assessment, assessment of disease extent and activity, disease monitoring in ulcerative colitis and Crohn’s disease, nutritional assessment, and colorectal cancer surveillance. These guidelines are intended to support individualized clinical judgment and should be applied flexibly, taking into account not only individual patient characteristics and clinical circumstances but also available resources, access to diagnostic and monitoring modalities, regulatory requirements, and reimbursement policies.
SN - 1598-9992
SN - 2233-6869
ER -